DelphX Capital Markets Inc. develops structured-product technology and financial services for broker-dealers. Through its special purpose vehicle Quantem LLC, the company enables private placement securities designed for fixed-income and cryptocurrency-based solutions, including Collateralized Put Options and Collateralized Reference Notes. News about DPXCF commonly covers non-brokered unit private placements, common-share and warrant terms, TSX Venture Exchange-related conditions, stock option grants under its option plan, and updates tied to structured-product distribution.
DelphX Capital Markets (DPXCF) has closed a non-brokered private placement, raising C$55,000 through the issuance of units.
The company issued 5,500,000 units at C$0.01 each, comprising one common share and one warrant. Each warrant permits the purchase of an additional common share at C$0.06 until November 6, 2028. DelphX intends to use the net proceeds for general working capital and corporate overhead. The offering remains subject to final TSX Venture Exchange acceptance. The securities have a hold period expiring March 7, 2027, and also carry an Exchange Hold Period because units were priced below C$0.05. Following closing, DelphX has 257,210,183 common shares outstanding.
DelphX Capital Markets (DPXCF) has commenced a non-brokered private placement targeting gross proceeds of up to approximately C$70,000. The offering comprises up to 7,000,000 units at C$0.01 each, with each unit containing one common share and one warrant exercisable at C$0.06 for two years from issuance. DelphX expects closing on or before October 26, 2026, subject to TSX Venture Exchange approval.
The DPXCF quotation has moved to Pink Limited. DelphX does not intend to maintain its OTC quotation, which may end in the coming months. Its primary TSX Venture Exchange listing under DELX and holders' shareholdings are unchanged.
DelphX Capital Markets (DPXCF) has appointed Emily Richardson, CPA, CMA, as chief financial officer, succeeding Simon Selkrig in the role. Richardson has more than 15 years of experience in public company finance, capital markets and corporate governance.
She also serves as chief financial officer of a publicly traded clean-tech company, overseeing financial reporting, audits, treasury and capital raising. Her experience includes capital planning, internal controls and finance system implementations. Richardson identified timely and accurate reporting, careful management of capital and clear shareholder communication as her priorities at DelphX.
DelphX Capital Markets (DPXCF) will adopt semi-annual financial reporting under the Canadian Securities Administrators' pilot program for certain venture issuers. It does not intend to file interim financial statements or related management's discussion and analysis for the three and nine months ended September 30, 2026, its first period using the exemption.
Audited annual and six-month interim reporting will continue. The next periodic filings cover the year ending December 31, 2026, and are due by April 30, 2027. Timely disclosure obligations remain unchanged. DelphX says the change reduces reporting costs and management time, allowing resources to be directed toward structured-product development and distribution.
DelphX Capital Markets (DPXCF) corrected its September 23, 2026 private placement closing announcement to report C$64,000 in gross proceeds. It issued 6,400,000 units at C$0.01 each, rather than the previously reported 6,100,000 units and C$61,000.
Each unit contains one common share and one warrant to buy another share at C$0.06 for two years from issuance. An insider subscribed for 500,000 units for C$5,000. DelphX plans to use the net proceeds for working capital and corporate overhead. Final acceptance remains subject to TSX Venture Exchange approval.
DelphX Capital Markets (DPXCF) closed a previously announced non-brokered private placement on September 23, 2026, issuing 6,100,000 units at C$0.01 per unit for gross proceeds of C$61,000.
Each unit comprises one common share and one warrant, with each warrant exercisable at C$0.06 for two years. An insider subscribed for 500,000 units (C$5,000), making the financing a related party transaction under MI 61-101; DelphX relied on valuation and minority approval exemptions, as the insider’s portion was under 25% of market capitalization. Net proceeds will fund working capital and corporate overhead. The financing remains subject to TSX Venture Exchange final acceptance, and all securities are subject to a four-month-plus-one-day statutory hold and an Exchange Hold Period.
DelphX Capital Markets (DPXCF) has launched a non-brokered private placement of up to 5,600,000 units at C$0.01 per unit, for gross proceeds of up to C$56,000.
Each unit comprises one common share and one warrant, with each warrant exercisable into one common share at C$0.06 for two years from issuance. DelphX plans to use net proceeds for working capital and corporate overhead, with no more than 10% of gross proceeds allocated to investor relations activities. The placement is subject to TSX Venture Exchange approval, and the securities will be subject to a four-month-plus-one-day hold period and the Exchange Hold Period.
DelphX Capital Markets (DPXCF) closed a non-brokered private placement on September 2, 2026, issuing 5,250,000 units at C$0.01 per unit for gross proceeds of C$52,500.
Each unit comprises one common share and one warrant, with each warrant exercisable at C$0.06 for two years. An insider subscribed for 100,000 units (C$1,000), making the transaction a related party transaction under MI 61-101; DelphX relied on valuation and minority approval exemptions as the insider’s participation was below 25% of market capitalization. Net proceeds will be used for working capital and corporate overhead, with no specific use exceeding 10% of gross proceeds. The financing is subject to TSX Venture Exchange approval, and the securities carry a four-month-plus-one-day hold and an Exchange Hold Period.
DelphX also reports that its Credit Rating Securities platform is under internal review by a top-tier global reinsurer and a global investment consulting firm, and it is in preliminary distribution discussions with an international structured products issuer and a major U.S. broker-dealer, though no binding agreements or revenue commitments exist.
DelphX Capital Markets (OTCQB: DPXCF, TSXV: DELX) has commenced a non-brokered private placement of up to 5,000,000 units at C$0.01 per unit, for potential gross proceeds of up to C$50,000. Each unit includes one common share and one warrant exercisable at C$0.06 for two years.
DelphX may pay finder's fees in line with TSX Venture policies and plans to use net proceeds mainly for working capital and corporate overhead, with no more than 10% for investor relations. The financing is subject to TSX Venture Exchange approval and the securities will carry a four-month-plus-one-day hold period and the Exchange Hold Period.
DelphX Capital Markets (OTCQB: DPXCF) closed two non-brokered unit private placements. On August 5, 2026 it issued 8,500,000 units at C$0.01 for gross proceeds of C$85,000, each unit comprising one common share and one warrant exercisable at $0.06 for two years. An insider subscribed for 1,500,000 units, and DelphX will pay C$700 in cash finder’s fees plus 70,000 finder’s warrants, all subject to TSX Venture Exchange approval and a four‑month‑plus‑one‑day hold.
DelphX also closed a previously announced placement on June 30, 2026, issuing 2,000,000 units at C$0.02 for gross proceeds of C$40,000 with identical warrant and hold‑period terms. According to DelphX, net proceeds from both offerings will be used for working capital and corporate overhead.